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Two human  molecules with surprisingly similar molecular structures,  LFA-1 
and  Mac-1/OKM1,  have  recently  been  found  to  be  important  in  cytolytic T 
lymphocyte-mediated killing, and in complement receptor function, respectively. 
Human LFA-1 contains two subunits of Mr 177,000 and 95,000 (1), and OKM 1/ 
Mac-1  (2) has two polypeptides of strikingly similar size.  Monoclonal antibodies 
(MAb)  to  human  LFA-1  block  antigen-specific  CTL-mediated  killing  and  T 
helper cell responses, as well as natural  killing (1,  3).  LFA-1 participates in the 
Mg+2-dependent adhesion step of CTL-mediated killing (4).  Human LFA-1 is a 
widely expressed leukocyte antigen  present in lymphocytes, thymocytes, mono- 
cytes, granulocytes, and 37% of bone marrow cells (3). The participation of LFA- 
1 in natural as well as antigen-dependent killing, and its distribution on myeloid 
(3) as well as lymphoid cells, suggest that LFA-1  is not an antigen receptor but 
has a different and perhaps more general function in cell adhesion reactions. 
MAb to  human  Mac-l(5)  block adhesion  by myeloid cells,  mediated  by the 
complement receptor type three (CRy), 1 to C3bi-coated particles (6).  Mac-1 may 
thus be identical to the CRy. Human Mac-1  (5) and its homologue murine Mac- 
1 (7-9) appear identical  to the human  OKM1  and  Mol  antigens  (2,  10-12) in 
cell  distribution  and  structural  characteristics.  Mac-l,  OKM1,  and  Mol  are 
expressed on monocytes, granulocytes, and natural  killer cells, and in contrast 
to LFA-1, are absent from lymphocytes. 
A  structural  relationship between molecules implies similarities in the molec- 
ular mechanisms  underlying their functions.  Here, relationships between LFA- 
1, OKM 1 (Mac-1), and further leukocyte cell surface antigens have been exam- 
ined.  The  results  show  that  human  LFA-1,  OKM1/Mol,  and  a  third  novel 
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molecule termed p150,95 each contain a- and/3-subunits that are noncovalently 
associated  in  an  al/3~-structure.  The  a-subunits  of Mr  177,000  to  150,000  of 
these three molecules differ, while the/3-subunits of Mr =  95,000 are identical. 
The molecules have been characterized biochemically, immunochemically, and 
functionally. 
Materials and Methods 
Monoclonal Antibodies.  Anti-LFA-1  MAb produced by the TS1  and TS2 subcloned 
hybridomas have been previously described (1). OKM 1 MAb was purchased from Ortho 
Pharmaceutical (Raritan, N  J) or was the kind gift of Dr. G. Goldstein, as were OKM9 and 
OKM 10 MAb. The  187.1  anti-mouse kappa chain hybridoma (13) was the kind gift of 
Dr. M. Scharff (Albert Einstein Medical School, NY). 
Cells.  Peripheral  blood  lymphocytes were  isolated  from  normal  adults  by  Ficoll- 
Hypaque density centrifugation (14) and removal of monocytes. Monocytes were purified 
by adherence to plastic tissue-culture dishes with subsequent release with xylocaine (I 5). 
Granulocytes were isolated from citrated blood by dextran sedimentation of erythrocytes 
followed by a  Ficoil-Hypaque gradient  (14).  Remaining erythrocytes were  lysed with 
hypotonic saline. Thymocytes were obtained from patients undergoing corrective cardiac 
surgery. CTL lines were as previously described (1).  Cell  lines JY, a  B lymphoblastoid 
line,  and  U937,  a  monoblast-like  line,  were  grown  in  RPMI  1640  medium  (Gibco 
Laboratories, Grand Island, NY) supplemented with 10% fetal calf serum (Gibco), 2 mM 
glutamine,  50 gM  2-mercaptoethanol, and 50 ~g]ml gentamycin. For induction, PMA 
dissolved in dimethylsulfoxide (14 ~g/ml) was added to a final concentration of 2 ng]ml 
to cultures of U937 cells. 2/3 of the medium was replaced with fresh medium containing 
PMA every 2 d.  For [35S]methionine  labeling,  10 ml of U937 cells at 4  ×  105/ml were 
cultured in  60-ram  tissue culture dishes  to  which  they became adherent.  For  ~5I  or 
fluorescent labeling, 5 ×  105 cells/ml were cultured in Teflon beakers (Nalgene 1500), to 
which they did not adhere. For rosetting assays,  104 U937 cells]well were induced for 4 
d in 96-well microtiter plates (Costar, Data Packaging, Cambridge, MA). 
Labeling,  Immunoprecipitation,  and  Electrophoresis of Cell Surface  Proteins.  Cells  were 
iodinated using chloroglycoluril (IODO-GEN, Pierce Chemical Co., Rockford, I L) (16), 
except for granulocytes, which  were enzymatically iodinated by the  glucose oxidase/ 
lactoperoxidase method (17).  For biosynthesis studies, U937 cell induced with PMA for 
3 d were washed with methionine-free RPMI 1640 + PMA +  10% dialyzed FCS, incubated 
with 1.2 ml of the same medium containing 140 #Ci [sSS]methionine for 15 or 30 rain, 
and then chased by rinsing and incubation in 5 ml of complete medium at 37 °C for the 
indicated times. Triton X-100 lysates were prepared as described (16) (in 10 mM Tris pH 
8.0,  0.14  M  NaCI,  1%  Triton  X-100,  1%  hemoglobin,  1.5  mM  PMSF),  except that 
[3"~S]methionine-labeled Triton X-100 lysates were subjected to centrifugation at 11,000 
g for 20 min in a microfuge, followed by addition of sodium deoxycholate to 1% and a 
second centrifugation at 100,000 g for 1 h. For immunoprecipitation, lysates were mixed 
with 75 t~l of MAb-containing culture supernatants, 30 ~1 of OKM1 MAb at 100 t~g/ml, 
or 20 #1 of 1:100 OKM10 ascites.  To isolate immune complexes, 100 #1 (7.4 #g) of the 
187.1  anti-mouse kappa chain MAb together with 50 t~l of a  10% suspension of Staphylo- 
coccus aureus  were  used  per  MAb.  In  some  experiments, antigens  were  isolated  with 
monoclonal antibodies coupled to Sepharose CL-4B at 1 mg]ml or with purified MAb or 
ascites in conjunction with 187.1 MAb coupled to Sepharose (2.5 mg/ml). Immunoprecip- 
itates were processed as previously described (18) and samples were subjected to SDS- 
PAGE and autoradiography with enhancing screens (19). 
Dissociation of a- and ~-Subunits  by High pH Treatment.  Cell lysates were mixed with a 
6-10-fold excess (vol/vol) of 50 mM triethylamine pH 11.5, 0.5 M NaCi, and 0.1% Triton 
X-100 for 30 rain at 0°C. Samples were neutralized by addition of 1/10 of final volume 
of 1 M Tris-HCI pH 6.8. 
Cross-linking.  Triton  X-100  lysates  were  cross-linked  with  0.1  mg/ml  dithiobis- 
(succinimidyl propionate) (Pierce Chemical Co.) as previously described (20). SANCHEZ-MADRID  ET  AL.  1787 
Two-dimensional (2-D) Electrophoresis.  For nonreducing-reducing 2D PAGE, immuno- 
precipitates were solubilized in Laemmli sample buffer containing 50 mM iodoacetamide 
for 5 min at 100°C and loaded on 0.3 cm ×  11.5 cm 5% polyacrylamide tube gels (first 
dimension, nonreducing) (21). A stacking gel was included. After completion of electro- 
phoresis the gels were extruded from the tubes and equilibrated in 0.0625  M Tris pH 
6.8, 10% glycerol,  5%/~-mercaptoethanol,  2.3% SDS, and 100 mM dithiothreitol at 21 °C 
for 30 rain and placed on  1.6-mm thick 7% polyacrylamide Laemmli slab gels (second 
dimension reducing). The 1% agarose SDS sample buffer solution used to seal the tube 
gels to the stacking gel contained 100 mM dithiothreitol. 
2-D electrophoresis, with isoelectric focusing in the first dimension and SDS-PAGE in 
the second dimension, was carried out using the procedure of O'Farrell as described by 
Jones (22), except that Triton X-100 was used in place of NP-40. Ampholytes (LKB) were 
a 4:1 mixture of pH 5-7 and pH 3.5-10. pH gradients were measured by cutting parallel 
blank gels  into 0,5-cm  sections. Gel slices were soaked overnight at  21°C  in  3  ml of 
distilled, deionized water in tightly capped  tubes before metering the pH.  pI marker 
proteins (Isogel pI markers, FMC Corporation) were also used. 
Flow Cytometry.  106 cells were labeled with 50 #1 TS1/12  or TS1/18  MAb culture 
supernatant containing "~ 100 #g antibody/ml or with purified OKM 1 MAb at 20 #g/ml, 
followed by washing and labeling with FITC-conjugated affinity-purified  goat anti-mouse 
IgG, 70 #g/ml (Zymed Laboratories, South San Francisco, CA) as previously described 
(16). Antibody titrations confirmed saturation labeling. 
CR~ Rosetting Assay.  Rosetting to U937 cells induced with PMA for 4 d was assayed in 
10  mM  HEPES-buffered  Hank's balanced  salt solution.  Sheep  erythrocytes (E)  were 
sensitized with an IgM anti-Forssman MAb and CS-deficient A/J mouse serum to generate 
E-IgM-C.  U937 cells were incubated with MAb for 1/2 h at 20°C before addition of E- 
IgM-C. Cells rosetting ~5 E-IgM-C were scored as positive. Procedures were as previously 
described (23), except for washing. After addition of 200 #1 of HEPES-Hank's, wells were 
sealed with tape (Dynatech Laboratories, Inc. Dynatech Corp., Alexandria, VA), inverted, 
and the trapped air bubble was gently gyrated. After 5 min the tape was removed and 
residual medium drained onto absorbent paper towels. Wells were washed thrice. 
Results 
Localization of Antigen Epitopes of the a- and [3-Subunits of  Human LFA-1.  During 
studies on a panel of MAb to human LFA-1, one MAb was noted to immunopre- 
cipitate an extra band from  l~5I-labeled CTL. While six of seven independent 
anti-LFA-1 MAb precipitated only the LFA-1 a  (otL)- and/3-subunits of 177,000 
and 95,000 Mr, respectively (Fig.  1 A, lanes 2-3 and 5-8), the TS1/18 anti-LFA- 
1 MAb additionally precipitated a  chain of 150,000  Mr denoted aX  (Fig.  1 A, 
lane  4).  The  aX-chain  was  seen  in  some  but  not all  preparations  of human 
cytolytic T  lymphocyte lines (cf. Fig. 2 of reference 1), perhaps due to variations 
in the presence of feeder cells. 
The  a-  and  B-subunits  of human  LFA-1  are  not  disulfide-linked,  but  are 
associated noncovalently in an alBl-complex (1). Previous work with mouse LFA- 
1 has shown the subunits can be dissociated with high pH  (23).  To determine 
whether the anti-human LFA-1  MAb bound to epitopes on the or- or O-subunits, 
the a- and/3-subunits were separated by brief exposure to pH  11.5, followed by 
neutralization and immunoprecipitation. Five of the MAb precipitated the LFA- 
1 a-subunit of 177,000 Mr with no associated 13-subunit (Fig. 1B, lanes 2, 3, 5, 7, 
and 8).  The determinant recognized by the TS2/4  MAb (Fig.  1B, lane 6) was 
lost after the high pH treatment. The TS1/18 MAb (Fig. 1 B, lane 4) precipitated 
the/3-subunit with aX but no aL associated. The precipitation of otX in addition 
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FIGURE  1.  Precipitation of native and pH-dissociated antigen from CTL by anti-LFA-1 MAb. 
*251-labeled CTL  lysates  were  immunoprecipitated  after  treatment  with  pH  7.8  buffer  as 
control (A) or at pH  1 1.5  to dissociate subunits  (B) as described in  Materials and  Methods. 
Immunopreciptation was with the following MAb: X63 myeloma as control, lane 1; TS1/1 1, 
lane 2; TS1/12, lane 3; TSI/18, lane 4; TS1/22, lane 5; TS2/4, lane 6; TS2/6, lane 7, TS2/ 
14, lane 8. Samples were subjected to SDS 10% PAGE and autoradiograpby. Mr was calibrated 
with previously described standards (16). 
aL/3-complex to dissociation. The/3-subunit clearly bears the TS1/18  determi- 
nant, since/3 is precipitated in the absence of o~X from thymocytes and uninduced 
U937 cells (see Fig. 4 below). Thus, out of seven different anti-LFA-1  MAb, five 
recognize epitopes on  the a-subunit and one recognizes an epitope located on 
the/3-subunit. 
The  anti-/3  MAb  precipitated  three  a-chains  of Mr  177,000,  165,000,  and 
150,000  in association  with the/3-subunit from granuiocytes (Fig.  2A,  lane 3). 
The  177,000 Mr e~-subunit co-migrated identically with aL precipitated by an 
anti-LFA-1  o~ MAb  (Fig.  2A,  lane  4).  The  a-subunit  of  150,000  Mr appeared 
identical to aX described above. Interestingly, the a-subunit of 165,000 Mr (Fig. 
2A, lane 3) co-migrated identically with the a-subunit precipitated by anti-OKM 1 
MAb  (Fig.  2  A,  lane  2).  The  anti-OKM1,  anti-B,  and  anti-LFA-~  MAb  all 
precipitated/3-subunits of identical Mr 95,000 (Fig. 2A, lanes 2-4). 
To determine which subunits bore the antigen epitopes, the  195I-granulocyte 
lysates were subjected to high pH to dissociate subunits, followed by neutraliza- 
tion and immunoprecipitation. The anti-OKM 1 MAb precipitated the OKM 1 
(~M)-chain with no/3-chain (Fig. 2B, lane 2), showing that the OKM1  epitope is 
on  the  o~M-chain.  The  OKM1  /3-chain  is  therefore  precipitated  from  native 
antigen preparations (Fig. 2A, lane 2), due to noncovalent association with the 
aM-chain.  The  TS1/18  anti-/3  MAb  precipitated  the  /3-subunit only (Fig.  2B, 
lane 3) and the TS1/22 anti-LFA-1 a  MAb precipitated the aL-subunit only (Fig. 
B, lane 4), confirming results obtained with the dissociated subunits from CTL. SANCHEZ-MADRID  ET  AL.  1789 
FIGURE 2.  Precipitation of native and pH-dissociated antigen from granulocytes, t25I-labeled 
granulocyte lysates were treated at neutral pH to preserve native subunit structure (A) or at 
pH  11.5 to dissociate subunits (B) as described in Materials and Methods.  Lysates were then 
immunoprecipitated  with  X63  as control,  lane  I; anti-OKM1  MAb,  lane 2;  TS1/18  anti-/3 
MAb, 1Jne 3; or TS1/22 anti-LFA-1  a  MAb, lane 4.  Immunoprecipitates were subjected to 
SDS 7% PAGE and autoradiography.  Only the relevant portion of the gel is shown. 
Identical  results  have  also  been  obtained  with  high  pH-dissociated  monocyte 
lysates (results not shown). 
The above experiments suggested that the anti-/3 MAb precipitated the same 
LFA-1  and  OKM1  antigens  as  precipitated  by  anti-aL  and  anti-aM  MAb, 
respectively. This hypothesis was tested with preclearing experiments. Granulo- 
cyte lysates were precipitated  (precleared)  with one MAb,  then the precleared 
supernatants were subjected to immunoprecipitation with a  second MAb. The 
amount of OKM1  antigen  precipitated  by  the anti-OKM1  MAb after  control 
preclearing with X63  (Fig.  3,  lane  1) was  greatly reduced by preclearing with 
the anti-/3  MAb  (Fig.  3,  lane  4).  Both  the  a-  and  /3-subunits were  precleared. 
Conversely, the amount of olM precipitated by the anti-/3  MAb (Fig.  3,  lane 2) 
was  greatly  reduced  after  preclearing  with  anti-OKM1  (Fig.  3,  lane  5).  The 
amount  of  /3-subunit  precipitation  by  anti-TS1/18  was  also  decreased.  This 
showed  that  a  substantial  amount  of  the  total  /3  present  in  granulocytes  is 
associated with the  OKM 1  a-subunit,  as would be  expected from the relative 
amount of the  three  a-subunits  (Fig.  3,  lane  2).  The  amount  of aL  and  aX 
precipitated by the anti-/3 TS1/18  MAb was unaffected by preclearing with the 
OKM 1 MAb (Fig. 3, lane 5 compared with lane 2). Similar results were obtained 
with LFA- 1. The TS 1  / 18 anti-/3 MAb precleared precipitation of LFA- 1 by the 
TS1/22 anti-LFA-1  a  MAb (Fig. 3, lane 9 compared with lane 7). The TS1/22 
anti-a MAb precleared aL-chain precipitation by the TS1/18 MAb, while having 
no effect on aM or aX precipitation (Fig. 3, lane  10 compared to lane 2). These 
results prove that the aM- and aL-subunits recognized by the OKM1  and TS1/ 
22 MAb, respectively, are associated with/3-subunits bearing a common epitope 
recognized by the TS1/18 MAb. 
The  TS1/18  anti-/3  MAb  was  the  only  MAb  studied  here  that  was  cross- 
reactive. The six antibodies that precipitated LFA-1 but not the otX-subunit (Fig. 
1  A) also did not precipitate OKM1  (not shown). The recently described OKM9 
and OKM 10 MAb have the same specificity as OKM 1 MAb for monocytes and 
granulocytes but not lymphocytes, and define topographically distinct epitopes 1790  THE  HUMAN  LFA-1,  OKM1/Mac-1,  AND  p150,95  FAMILY 
FIGURE 3.  The same OKM1  or LFA-I molecules are precipitated by anti-//or the relevant 
anti-a MAb.  ~SI-granulocyte lysates  were first immunoprecipitated with the indicated "pre- 
clearing antibody." X63 myeloma antibody was  used as a  control. The resulting precleared 
supernatants  were then immunoprecipitated with the indicated "precipitating antibody." The 
latter immunoprecipitates were subjected to SDS 7% PAGE and autoradiography.  Only the 
upper portion of the gel is shown. 
on  the  OKM1  molecule (24).  OKM9  (not shown) and  OKM10  MAb  (Fig.  8 
below) precipitated OKM 1 but not LFA-1 or aX. 
oq/31-Subunit Structures.  To examine the subunit structure of these antigens, 
cross-linking experiments were carried out. Monocytes which bear OKM 1, LFA- 
1, and in particular abundance, aX (Fig. 6A below), were used in these studies. 
Detergent-solubilized lysates were subjected to cross-linking with the cleavable 
reagent dithiobis(succinimidyl proprionate) and immunoprecipitated with either 
an anti-aM MAb, an anti-otL MAb, or the anti-/3 MAb. The cross-linked, immu- 
noprecipitated material was analyzed by 2-D nonreduced-reduced, SDS-PAGE 
in which the cross-linker was cleaved with 0.1  M dithiothreitol before electro- 
phoresis in the second dimension, thereby dissociating the cross-linked products 
into their constituent polypeptide chains (Fig. 4, a, c, and e). In the first dimension 
cross-linked products of Mr 250,000-270,000  were found for OKM1  (Fig. 4a), 
LFA-1 (Fig. 4c), and the three antigens precipitated by the anti-/3 MAb (Fig. 4e). 
Upon reduction in  the  second dimension the cross-linked OKM1  and  LFA-1 
products were cleaved into the OKM1 a- and/3-chains of  Mr 165,000 and 95,000 
(Fig.  4a) and the LFA-1  a- and/3-chains of Mr  177,000  and 95,000  (Fig.  4c), 
respectively. The fact that  the a- and/3-bands are vertically aligned with each 
other in the second dimension, below the diagonal of uncross-linked proteins, 
indicates that both subunits are present in the cross-linked products. The molec- 
ular weights of cross-linked products in the first dimension of Mr 260,000  for 
OKM1 and Mr 270,000 for LFA-1 show that they are of the composition a~/31. 
In the cross-linked anti-/3 precipitate (Fig.  4e), the identity of cross-linked a- 
chains was confirmed by comparison of their mobility and intensity in side-by- SANCHEZ-MADRID  ET  AL.  1791 
FIGURE 4.  2-D SDS-PAGE of cross-linked and noncross-linked OKM 1, LFA-1 and p150,95. 
Cross-linked or uncrosslinked lysates (150 ul), as indicated in the figure, were immunoprecip- 
itated with anti-OKMl  a  MAb (using 100  ul of 0.1  mg/ml OKM1  and  100 ~1 of 187.1- 
Sepharose) (a and b), TS1/22 anti-LFA-1 a  MAb (using 100 ~1 of TS1/22-Sepharose) (c and 
d), and TS1/18 anti-LFA-1 3 MAb (using 100 ~1 of TS1/18-Sepharose (e and/). Immunopre- 
cipitates were subjected to SDS-PAGE under nonreducing conditions in 5% polyacrylamide 
tube  gels  (first  dimension) followed  by  electrophoresis  under reducing conditions in  7% 
polyacrylamide slab gels (second dimension). Control immunoprecipitates with rat IgG Seph- 
arose (1 mg/ml) run in parallel gels showed no specific spots (data not shown). The molecular 
weights of the cross-linked species were determined by SDS 5% PAGE in one dimensional slab 
gels under nonreducing conditions with molecular weight markers. Molecular weights in the 
reduced dimension were determined with markers loaded to the left of the focusing gel. The 
streaks visible in (b) and (/') are due to leakage of these markers. In (g),  the mobilities and 
intensities of the different a  chains precipitated by anti-3 and anti-3 MAb were compared 
using  the same cross-liked lysate preparation in a reducing one dimensional  slab system identical 
to that employed in the second dimension of a-f.  Antigens were isolated with OKM 1 and 
187.1-Sepharose (lane I), TSl/18-Sepharose (lane 2),  TS  1/22-Sepharose  (lane 3),  and rat 
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FIGURE 5.  Immunofluorescence flow  cytometry of peripheral blood monocytes, granulo- 
cytes,  and lymphocytes.  Cells  were  labeled with  saturating concentrations of monoclonal 
antibodies OKM 1, TS 1/12, and TS 1/18 (continuous curves) or X63 control antibody (dotted 
curves), followed by fluorescein isothiocyanate-anti-mouse IgG, and analyzed on a  FACS II. 
Relative fluorescence intensity was  calibrated with glutaraldehyde fixed sheep erythrocyte 
standards (16).  Multiple peaks on PBL indicate subpopulations of cells with differing antigen 
densities. 
side 1-D SDS-PAGE of the three different cross-linked immunoprecipitates under 
reducing conditions (Fig. 4g). aL and aX were much more prominent than aM 
in the anti-/3 precipitate (Fig. 4g, lane 2). aL (Fig. 4g, lane 3) migrated near to 
o~M (Fig. 4g, lane 1) and obscured aM in the analysis of anti-/3 precipitates in  1- 
D (Fig. 4g, lane 2) and 2-D (Fig. 4 e). In 2-D SDS-PAGE, cross-linked aX migrated 
at a  slightly lower Mr than  cross-linked aL in  the first dimension (Fig.  4 e), as 
expected from the lower M, of an aX/3- than an ~L/3-complex. Cross-linked aX 
was vertically aligned with cross-linked/3. This, and the Mr 250,000 of the cross- 
linked product in the first dimension, show that aX is associated with/3 in an 
aX1/31-complex.  Henceforward, this molecule will be designated according to the 
molecular weights of its polypeptides as p150,95. 
Some uncross-linked a- and/3-chains were present on the diagonal in all cross- 
linked immunoprecipitates (Fig.  3,  a,  c,  and  e).  Since  uncross-linked a-chains 
were present in anti-/3 precipitates and vice versa, the uncross-linked material is 
due to the lack of 100% efficiency in cross-linking. 
Parallel  experiments,  with  the  cross-linking  omitted,  were  carried  out  to 
determine whether any normally occurring disulfide-linkages were present. For 
OKM1  (Fig.  4b),  LFA-1  (Fig.  4d), and OKM1,  LFA-1, and p150,95  together 
(Fig.  4)0,  the a- and/3-subunits were seen along the diagonal, again confirming 
the  noncovalent association  of the  a-  and  /3-subunits  in  each  of these  three 
antigens. 
bnmunofluorescent  Staining by Anti-a and Anti-/3 MAb.  The expression of aL-, 
aM-, and/3-subunits on peripheral blood lymphocytes, monocytes, and granulo- 
cytes, was quantitated with immunofluorescence flow cytometry. Monocytes and 
granulocytes (Fig. 5, a and b) expressed the OKM 1 aM-subunit but only a small 
percentage of lymphocytes, probably  corresponding to  "null"  cells (1 l),  were SANCHEZ-MADRID ET  AL.  1793 
weakly positive  for aM  (Fig.  5c).  Lymphocytes  were strongly  aL  + and  demon- 
strated  two subpopulations  differing  in quantitative  expression  (Fig.  5~.  Mono- 
cytes also expressed the LFA- 1 a-subunit (Fig. 5 d), and granulocytes were weakly 
LFA-1  a  positive  (Fig.  5e).  The  ratio  of OKM1  a  to  LFA-1  a  expression  was 
1.5:1  on  monocytes  and  7:1  on  granulocytes,  respectively.  On  monocytes  and 
granulocytes,  the  fluorescence  intensity  given  by the anti-/3  MAb (Fig.  5, g  and 
h) was greater  than  for either anti-aL  or anti-aM  alone.  On lymphocytes, which 
express  only  LFA-1,  the  fluorescence  intensity  given  by anti-aL  and  by anti-/3 
MAb was identical  (Fig.  5,land  i). 
a- and O-Structures on Other Cell Types.  The expression of LFA-1, OKM 1, and 
other  members  of  this  family  sharing  the  same  /3-subunit  was  examined  by 
immunoprecipitation  in  a  number  of  other  types  of  cells.  Blood  monocytes 
expressed  both  the  OKM1  and  LFA-1  antigens  (Fig.  6A,  lanes  2  and  4).  The 
anti-/3 MAb precipitated  from monocytes aL, aM, and in greater quantities than 
had been  seen in other cell types, aX  (Fig.  6A,  lane 3).  A  weak band  migrating 
below aX  was also seen  (Fig.  6A,  lane 3).  In the JY B  lymphoblastoid  cell line, 
LFA-1  was precipitated  by the anti-LFA-1  a  and  anti-/3  MAb (Fig.  6B,  lanes  4 
and 3), but no OKM1  was seen (Fig. 6B, lane 2). A  band possibly corresponding 
to aX was precipitated  by the anti-~  MAb (Fig.  6 B, lane 3).  In thymocytes, only 
LFA-1  was precipitated  (Fig.  6C,  lanes  3  and  4).  In  the  U937  immature  mon- 
oblast-like cell line,  LFA-1  was precipitated  by anti-a  and anti-/3  MAb, but little 
or no OKM1  or p150,95  were present  (Fig.  6D,  lanes 3  and  4).  Phorbol  esters 
induce  maturation  of U937  cells (25).  After  1 d  of culture  of U937  cells  with 
phorbol ester,  aX in addition  to aL was detected with the anti-O MAb (Fig.  4E, 
lane 3). OKM 1 gradually increased after  1 d  of culture reaching maximum  levels 
at day 5, while LFA-1  gradually decreased (data not shown and cf. Fig.  7). 
aX  did  not  appear  to be a  degradation  product  of aM  or  aL  because of its 
differing expression during maturation  of U937 and its lack of multiple epitopes 
present  on  aM  and  aL.  Furthermore,  the  same  amount  of aX  was  obtained 
whether  monocytes were lysed in the standard  buffer containing  phenyimethyl- 
sulfonyl fluoride  (PMSF),  or in  buffer containing  additionally  aprotinin,  iodoa- 
cetic acid,  and N-ethyl  maleimide;  and  whether  the  lysates were dialyzed  over- 
night  at  4°C,  or  held  at  -80°C.  Moreover,  aX  was  not  generated  when  125I- 
FIGURE 6.  Immunoprecipitation  of OKM 1, LFA-I, and related antigens from different cell 
1251  sources. Lysates O  f  I-labeled monocytes (A), JY B lymphoblastoid cells (B), thymocytes (C), 
U937  myelomonocytic cells (D), or U937 myelomonocytic cells cultured  1 d with phorbol 
ester (E) were immunoprecipitated  with X63 as control (lane I), anti-OKM1 a MAb (lane 2), 
TS1/18 anti-LFA-1 /3 MAb (lane 3), or TS1/22 anti-LFA-1 a MAb (lane 4). Immunoprecipi- 
tates were subjected to SDS  10% (A-C,  C is a separate  gel) or  7% (D and E) PAGE and 
autoradiography. Only the upper portion of gels are shown. 1794  THE  HUMAN  LFA-1, OKM1/Mac-1,  AND  p150,95  FAMILY 
labeled OKM 1 isolated  with  OKM 10  MAb and anti-kappa MAb Sepharose was 
mixed with a lysate of unlabeled monocytes prepared under standard conditions, 
and held overnight at 4°C (data not shown).  Thus,  it is extremely unlikely that 
aX is an artifact of proteolysis occurring during antigen isolation in vitro. 
Biosynthesis Studies.  It  was  important  to  further  test  whether  aX  was  an  in 
vivo degradation  product  of aL  or  aM,  or  whether  it  represented  a  de  novo 
biosynthetic product.  It was also of interest  to determine whether the a- and/3- 
subunits  of a  given antigen  were  derived  from separate precursors,  or from a 
single precursor by proteolysis. For biosynthesis studies, U937 cells induced with 
phorbol ester for 3  d  were pulse-labeled with [35S]methionine for 0.25 or 0.5  h, 
chased  for varying periods  of time with  "cold"  methionine,  and  then  lysed and 
subjected to immunoprecipitation.  For comparison to mature polypeptide chains 
on the cell surface, cells surface-labeled with  125I were  also immunoprecipitated. 
The biosynthesis of LFA-1  was studied  using an anti-otL MAb (Fig.  7 C).  The 
aL-chain was derived  from a  precursor of 170,000  Mr denoted  a'L  (Fig.  7C), 
lanes  18-20).  The  mature  aL-chain  was  first  seen  at  1  h  of chase,  in  greater 
quantities at 2 h, and was the only product at 4 and 22 h  of chase (Fig. 7C, lanes 
20-23).  Mature H-chain was weakly seen at 4  and  22  h  of chase (Fig.  7 C,  lanes 
FIGURE 7.  Biosynthesis of LFA-I, OKM1, and p150,95.  U937 cells cultured  in PMA for 3 
d in petri dishes were pulse-labeled with [s~S]methionine for 0.25 or 0.5 h, then washed and 
chased with "cold" methionine  for the times indicated in the figure in hours. Alternatively, 
U937 cells were cultured  in PMA for 3 d in Tefon beakers and surface-labeled with 12sI as 
indicated in the figure. Lysates were immunoprecipitated  with the anti-aM OKM 10 MAb (A), 
the anti-/~ TS1]18 MAb (B), or the anti-aL TS1/22 MAb (C), and subjected to SDS 7% PAGE 
125  SS  and fluorography (39) with an enhancing screen. There was less  I-aM than  S-aM in anti- 
aM and in the anti-/~  precipitate relative to other antigens; these measurements of the amount 
of OKMI accumulated on the surface and the rate of synthesis would be expected to differ 
because OKM1 is only starting to be induced at day 3. SANCHEZ-MADRID  ET  AL.  1795 
22 and 23). 
The  pattern  of OKM1  biosynthesis appeared  similar  (Fig.  7A).  An  a'M- 
precursor of 160,000 Mr was seen after chase for 0-0.5 h (Fig. 6A, lanes 2 and 
3) and was partially (1-2  h  of chase) and then fully converted (4 and 22  h  of 
chase) to the mature aM-subunit (Fig. 6A, lanes 4-7). The a'M- and aM-chains 
could be seen to be clearly resolved from one another in shorter autoradiogram 
exposures (not shown). A/3-chain precursor (/3') of Mr 90,000  was seen weakly 
at  1 h  of chase and more strongly at 2  and 4  h  of chase (Fig.  6A,  lanes 4-6). 
Conversion  to  the  mature /3-subunit  of Mr  95,000  was  seen at  4  h  and  was 
complete by 22 h (Fig. 6A, lanes 6 and 7). These findings suggest that association 
of the/3'-precursor with the a'M- or aM-subunit does not occur until  1 h, and 
precedes  processing  to  the  mature  /3-subunit.  As  expected,  the  [35S]labeled 
mature aM- and/3-subunits (Fig. 7A, lane 7) were identical in molecular weight 
to the 125I-labeled cell surface subunits (Fig. 7A, lane 8). 
The anti-/3 precipitates were more complex (Fig. 7B). Both a'M and a'L could 
be  seen after chase  for 0.5  or  1  h  (Fig.  7B,  lanes  11  and  12), showing that 
association with/3' or/3 can precede a-subunit processing. After 4-22 h of chase, 
a'M and a'L gave rise to higher molecular weight aM- and aL-subunits (Fig. 
7B, lanes 14 and 15) identical to those seen in anti-aM and anti-aL precipitates. 
The/3'-precursor was readily seen in anti-/3 precipitates beginning at 0 h of chase, 
and  was  largely although  not  completely converted to  the  mature  /3-subunit 
between 1 and 22 h of chase. 
Additionally, aX was present in the anti-/3 precipitates. The aX-precursor was 
seen at 0  h  of chase, did not change in molecular weight during 22 h  of chase 
(Fig. 7B, lanes 10-15), and was identical in size to 1~I surface-labeled aX (Fig. 
7B,  lane  16).  The aX-precursor was clearly distinct in size from a'M and a'L 
and appeared with the same kinetics. Thus, it does not appear to be related by 
processing or degradation to a'L, a'M, aL, or aM. 
Isoelectric Focusing  of the LFA-I, OKM1, and p150,95 Molecules.  Differences and 
identities among the subunits  of the  LFA-1,  OKM1,  and  p150,95  molecules 
isolated from monocytes were examined by 2-D isoelectric focusing-SDS-PAGE 
(Fig.  8).  aL,  aM,  aX,  and/3 each focused as discrete series of spots.  Multiple 
closely spaced spots are typical of glycoproteins with sialic acid charge heteroge- 
neity. The OKM1  a-subunit focused at pI 5.9-6.1, while the/3-subunit focused 
at  pI  5.2-5.5  (Fig.  8A).  The  LFA-1  a-subunit  was  more acidic  than  that  of 
OKM1,  focusing at  pI  5.1-5.5  (Fig.  8B).  The  /3-subunit  of LFA-1  focused 
identically to that of OKM 1. 
The anti-/3 precipitate contained bands corresponding to aM, aL, aX, and the 
/3-subunit (Fig.  8c).  The positions of aM and aL isolated with the anti-/3 MAb 
(Fig.  8c)  were  the  same as  after  isolation  with  anti-a  MAb  (Fig.  8,a  and  b, 
respectively). The aX-band focused between pI 5.8 and 6.1, closer to aM than 
to  aL.  Importantly,  the  pattern  seen  for the  /3-subunit  of all  three  antigens 
together (Fig. 8c) was superimposable with that seen for the individual OKM1 
and  LFA-1  /3-subunits  in  Fig.  8,a  and b,  respectively. This  shows that  the /3- 
subunits of LFA-1, OKM1, and p150,95  exactly co-migrate in isoelectric focus- 
ing, and it therefore appears that they are identical. 
Inhibition of the CRa.  MAb to OKM1  were tested for inhibition of the CR3- 1796  THE  HUMAN  LFA-1,  OKM1/Mac-1,  AND  p150,95  FAMILY 
FIGURE 8.  lsoelectric Focusing SDS-PAGE 2-D Gel Electrophoresis. Lysates (75 #1) of 12hi- 
labeled monocytes were immunoprecipitated with (a) the anti-OKM  10KM 10 MAb (30 ul of 
1:100 ascites)  and  30  ul  187.1-Sepharose,  (b) TS1/22-Sepharose  (30  #1), and  (c)  TS1/18- 
Sepharose  (30  #1). lmmunoprecipitates were  subjected  to  isoelectric  focusing in  the  first 
dimension followed by SDS  7%  PAGE under reducing conditions in the second dimension. 
Focusing was for 10,000 Volt-hours. Identical pI's were estimated for the a- and 13-subunits in 
a parallel run after focusing for 5,000 Volt-hours, showing equilibrium was reached. 
mediated rosetting of E-IgM-C by U937 cells induced  for 4  d  with PMA (Fig. 
9). Antibody to the CR~ had little or no effect on E-IgM-C rosetting, confirming 
that rosetting was due to the CR3 as previously reported for these indicator cells 
(6, 26). The CR3 was completely inhibited  by the OKM 1 and OKM 10 anti-aM 
MAb and  only slightly  by the  OKM9 putative anti-aM  MAb and  the  TSI/18 
anti-~  MAb in  a  dose-dependent  fashion.  The  TS1/22  anti-aL  MAb,  and  the 
W6/32  anti-HLA-A,B  MAb,  which  bind  to induced  U937  cells had  no effect, 
demonstrating the specificity of this inhibition. 
Discussion 
This  report  describes  the  interrelations  among  a  family  of  three  human 
leukocyte differentiation antigens.  The three antigens have very similar subunit 
structures. They contain an a-subunit of Mr 177,000 to 150,000, depending on 
the antigen, and a fl-subunit of Mr 05,000.  The LFA-1, OKM1, and p150,95 a- 
subunits are designated aL =  177,000 Mr, aM =  165,000 Mr, and aX =  150,000 SANCHEZ-MADRID  ET AL.  1797 
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FIGURE 9.  Inhibition of the  complement receptor  type  three.  Induced U937  cells  were 
incubated for J/~ h with MAb at the indicated dilutions, then challenged with E-IgM-C, and 
rosetting cells were enumerated microscopically as described in Methods.  Stock antibodies 
from which dilutions were made were culture supernatants for W6/32, TS1/18, TS1/22, and 
X63, 200 #g/ml purified antibody for OKMI, 1:50 ascites for OKM9, and 1:100 ascites  for 
OKM 10. Anti-CR~ was added at  12 #g/well. U937 cells challenged with E-IgM control cells 
gave 0% rosetting. 
34, respectively. In each antigen the subunits are noncovalently associated in an 
a~  quaternary structure. The OKM1 antigen had previously been reported to 
contain  two  polypeptide  chains  of  155,000  and  94,000  Mr  (2),  in  reasonable 
agreement with the Mr reported here, but it was not previously known to which 
chain(s) the  MAb bound or whether the chains were noncovalently associated. 
Subunit association is stable at neutral pH in the mild detergents Triton  X-100 
and  deoxycholate,  but  is  disrupted  by pH  11.5  and  by SDS.  The  subunits  of 
p150,95 are more stable to high pH dissociation than those of LFA-1 and OKM 1. 
The ability of high pH to dissociate subunits with retention of most antigenic 
determinants  played a  key role in the assignment of distinct and cross-reactive 
antigen  epitopes  to  particular  subunits.  The  TS1/18  MAb  precipitates  the 
dissociated  /3-subunit  and  cross-reacts  with  the  native  LFA-1,  OKM1,  and 
p150,95  a/3-complexes,  demonstrating  that  their  /3-subunits  bear  a  common 
antigen  epitope.  Furthermore,  the  B-subunits  of the  three  different  antigens 
exactly co-migrate  in  2-D isoelectric focusing-SDS-PAGE.  Since isoelectric fo- 
cusing is sensitive to a single charge difference, it appears that the/3-subunits are 
identical. 
The three a-subunits differ in immunochemical, physicochemical, and biosyn- 
thetic  properties.  The  5  MAb found  here  to  recognize  the  LFA-1  a-subunit 
appear to define four distinct epitopes as shown by cross-inhibition  studies (27). 
Since none  of these anti-aL  MAb cross-react  with  OKM1  or p150,95,  the aL 
subunit bears multiple determinants not present on o~M or (~X. The (~M-subunit 
bears the OKM 1 epitope, which is not present on (~L or aX. Furthermore,  anti- 1798  THE  HUMAN  LFA-1,  OKM1/Mac-I,  AND  p150,95  FAMILY 
OKM9 and anti-OKM 10 MAb, which recognize two other epitopes on the OKM 1 
molecule (24),  do not cross-react with LFA-1  or p150,95,  aX is distinct in its 
lack of four epitopes present on aL and three epitopes present on aM. Further 
characterization of p150,95  would be facilitated by MAb specific for the aX- 
subunit.  Besides  these  multiple  differences in  antigen  epitopes,  the three  a- 
subunits differ in physicochemical properties, as shown by 2-D isoelectric focus- 
ing-SDS-PAGE. 
The biosynthetic precursors of aL, aM, aX, and/3 are distinct and appear with 
similar kinetics, suggesting that they are not interrelated by processing and are 
products  of distinct  genes.  The  a'L-,  a'M-,  and  ~'-  but  not  a'X-precursors 
increase in size during maturation, perhaps due to carbohydrate processing. The 
precursors can assemble into the al~l-complexes before processing. The utiliza- 
tion of separate precursors for each subunit would require only a single/3-gene 
for all three types of a~-complexes. The same biosynthetic pathway has been 
previously demonstrated for the mouse Mac-1  and LFA-1 antigens (28). 
Although they can be readily distinguished by their antigenic and physico- 
chemical properties,  the  three  a-subunits  share  certain  characteristics.  They 
possess a region which is complementary to the ~-subunit, conferring the speci- 
ficity for the a-~ interaction, and their molecular weights differ by <20%.  In 
analogy to other protein families that share a common subunit, such as the class 
I histocompatibility antigens, hemoglobins, and immunoglobulins, it is predicted 
that the aL-, aM-, and aX-subunits are homologous in amino acid sequence and 
arose by gene duplication. 
The expression of the aL-,  aM-, and aX-subunits is selectively regulated in 
leukocyte differentiation.  Lymphoid  cells,  i.e.  thymocytes, peripheral  blood 
lymphocytes, T  lymphoma cells (unpublished observations),  B  lymphoblastoid 
lines, and CTL, are LFA-1 +, OKMI-, and low or negative in p150,95.  Granu- 
iocytes and monocytes express all three antigens, but granulocytes express OKM 1 
>  LFA-1  >  p150,95,  while blood  monocytes express similar quantities  of all 
three molecules. In the mouse, as in the human, lymphoid cells are LFA-1 + Mac- 
1- (29) and monocytes are LFA-1 + Mac-1 + (Springer unpublished). More differ- 
entiated thioglycollate-elicited macrophages are LFA-1- Mac-1 + (29). An inter- 
esting subject for further research is the mechanism that coordinates the recip- 
rocal relationship between aM and aL expression during monocyte maturation, 
and the selective expression of the OKM1,  LFA-1, and p150,95  a-subunits in 
leukocyte differentiation. 
The previously described murine LFA-1 and Mac-1 molecules (4) are identical 
in cell distribution, function, and structure to human LFA-1 and OKM1/Mac-1. 
Furthermore, the murine LFA-1  and Mac-1  a-subunits bear distinct, noncross- 
reactive epitopes  and  the  ~-subunits  bear  common,  completely cross-reactive 
epitopes  as  shown  with  both  monoclonal  and  conventional  antibodies  (23). 
Peptide mapping has also shown the Mac-1  and LFA-1  a  subunits differ while 
the/3-subunits are identical (29, 30). The finding that human LFA-1 and OKM 1 
also  have  shared  ~8-subunits  confirms  the  homology between  the  mouse and 
human families. The conservation of this family, its functions, and its subunit 
organization in evolution reinforces its importance. Although an aX equivalent 
has not been definitively characterized in the mouse, a third type of a-subunit of SANCHEZ-MADRID  ET  AL.  1799 
155,000 Mr has been found to be precipitated by an anti-/3 MAb (23). 
It  is  interesting to  compare the  functional activities of human  LFA-1  and 
OKM1/Mac-1.  The  function of the novel p150,95  molecule is  currently un- 
known. The human LFA-1 antigen appears to participate in several types of cell- 
cell interactions. MAb to it block both antigen-specific T  lymphocyte-mediated 
killing and natural killing. Blockade is due to binding of anti-LFA-1 MAb to the 
CTL effector rather than to the target cell (3). An independently obtained MAb 
to human LFA-1  has also been reported to block antigen-specific and natural 
killing (31). Anti-LFA-1 MAb also inhibit T  cell proliferative responses to antigen 
and to mitogen (3, 31). In the mouse system, anti-LFA-1 MAb has been shown 
to block the adhesion of CTL to target cells (4). 
Human Mac-l, OKM 1, and Mol, which appear to be equivalent, were originally 
defined as  differentiation  antigens  present  on  monocytes, granulocytes,  and 
"null" cells with NK and ADCC activity, but absent from lymphocytes. OKM1 
and Mo 1 were defined with mouse anti-human MAb (10-12); human Mac-1 was 
defined with  a  cross-reactive rat  anti-mouse  Mac-1  MAb (5).  The anti-Mac-1 
MAb has been shown to block the mouse and human receptor for C3bi, termed 
the complement receptor type three (CR3) (6). This suggests Mac-1  and the CR3 
may be identical. It was found here that the OKM1  and OKM10  MAb to the 
aM-subunit also inhibit the CR3.  The OKM9 MAb, which binds to a  different 
epitope (24) presumably on the aM-subunit, and the TS1/18 MAb, which binds 
to the/3-subunit, were much less inhibitory. These differences suggest that the 
C3bi ligand-binding site may be on the a-subunit near the OKM1 and OKM10 
epitopes. Anti-Mol (32) and anti-OKM 1 and OKM10 MAb, but not anti-OKM9 
MAb (33), have independently been found to block the CR3. 
Despite the differences in  function between Mac-1/OKM1/Mol and LFA-1, 
there are also common features.  Both  molecules act to  strengthen adhesions 
between effector cells and target cells. In both cases, it appears that the partici- 
pation  of additional  cell  surface molecules is  required for optimal  functional 
activity. LFA-1 acts together with the antigen receptor in CTL-mediated killing 
(1, 4).  Similarly, the CR3  acts synergistically with the Fc receptor to stimulate 
phagocytosis by  macrophages and  granulocytes (34)  and  killing  by antibody- 
dependent cytotoxic effectors (35).  Another  interesting parallel  is  that  both 
CTL-target cell adherence (36)  and adherence through the CR3  (37,  38)  are 
dependent on  divalent cations.  In  contrast,  CR1  and  FcR adherence are not 
divalent cation-dependent (38). 
The findings on the relationship between the human LFA-1 and OKM I/Mac- 
1 molecules allow some predictions about structure-fucntion relationships. The 
identities between the/3-subunits and differences between the a-subunits suggest 
that  the a-subunits  govern  the specificity of cell adhesion  reactions, i.e.  bear 
iigand-binding sites. The identical/3-subunit is predicted to mediate a common 
function.  It  might  be  involved  in  the  divalent cation-dependence and  might 
function in signal transduction or in regulation. 
Summary 
The  human  lymphocyte function-associated antigen-1  (LFA-1),  the comple- 
ment receptor-associated OKM 1 molecule, and a previously undescribed mole- 1800  THE  HUMAN  LFA-1,  OKM1/Mac-1,  AND  p150,95  FAMILY 
cule  termed  p150,95,  have  been  found  to  be  structurally and  antigenically 
related. Each antigen contains an a- and 13-subunit noncovalently associated in 
an  all31-structure as shown by cross-linking experiments.  LFA-1, OKM1,  and 
p150,95  a-subunit designations and their molecular weights are 0~L ---  177,000 
Mr, aM =  165,000 Mr, and aX =  150,000 Mr, respectively. The/3-subunits are 
all -- 95,000 Mr. Some MAb precipitated only LFA-1, others only OKM1, and 
another precipitates all three antigens. The specificity of these MAb for particular 
subunits was examined after subunit dissociation by high pH. MAb specific for 
LFA-1 or OKM1 bind to the otL- or aM-subunits, respectively, while the cross- 
reactive MAb binds to the 13-subunits. Coprecipitation experiments with intact 
al/3~-complexes  showed anti-or and anti-/3  MAb can precipitate the same mole- 
cules. In two-dimensional (2D) isoelectric focusingoSDS-PAGE, the a  subunits of 
the three antigens are distinct, while the/3-subunits are identical. Biosynthesis 
experiments showed aL, aM, and aX are synthesized from distinct precursors, 
as is/3.  The three antigens differ in expression on lymphocytes, granulocytes, 
and monocytes. During maturation of the monoblast-like U937 line, aM and otX 
are upregulated and aL is downregulated. Some MAb to the a subunit of OKM 1 
inhibited the  complement receptor  type three.  LFA-1,  OKM1,  and  p150,95 
constitute a  novel family of functionally important human leukocyte antigens 
that share a common/3-subunit. 
Note added in proof" The LFA-1, Mac-1/OKM1/Mol,  p150,95  family appears 
clinically important.  Several  patients  with  recurrent  bacterial  infections have 
defective  granulocyte adherence  functions and  lack  specific  high  molecular 
weight proteins (40-43).  Studies on one of these patients show his granulocytes 
lack the cell  surface proteins normally precipitated by anti-aM and anti-/3 MAb 
(44). 
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